
New Prostate Cancer Screening Guidelines: What Central Minnesota Men Should Know
A new prostate cancer screening guideline may change when many men begin routine PSA testing.
As highlighted by KFF Health News, the American Cancer Society updated its prostate cancer screening recommendations on November 12, 2026. The organization now directly recommends regular PSA blood tests for many men ages 45 to 69, depending on their risk.
At Aslan Health, we know screening decisions can feel confusing. Recommendations have changed over the years, and different health organizations do not always give identical advice. Here is what men and families in St. Cloud and throughout Central Minnesota should understand.
What Is a PSA Test?
PSA stands for prostate-specific antigen. The prostate naturally produces this protein, and a PSA test measures its level in the blood.
A high PSA result does not automatically mean that someone has prostate cancer. An enlarged prostate, inflammation, infection, recent medical procedures, and other noncancerous conditions can also raise PSA levels. In addition, there is no single PSA level that can diagnose cancer by itself.
However, PSA testing may help find prostate cancer before it spreads. Earlier detection can make some aggressive cancers easier to treat and may reduce the risk of dying from the disease.
What Does the New Prostate Cancer Screening Guideline Recommend?
The American Cancer Society’s 2026 guideline recommends different screening schedules based on age and risk.
Men at average risk
Men at average risk should receive a PSA test every two years from ages 50 through 69.
Black men
Black men should begin annual PSA screening at age 45 and continue through age 69. This earlier schedule reflects the higher burden of prostate cancer among Black men.
Men with a family history
Non-Black men with a father, brother, or son who has had prostate cancer should generally begin screening at age 45.
Annual screening is recommended when:
- A close relative was diagnosed before age 65.
- More than one close relative has had prostate cancer.
Screening every two years is recommended when only one close relative was diagnosed at age 65 or older.
People with an inherited genetic change associated with prostate cancer, such as a BRCA2 mutation, should discuss a personalized screening plan with a healthcare professional.
Although the guideline uses the word “men,” anyone who has a prostate may benefit from discussing prostate health and personal risk with a qualified healthcare professional.
What About Screening After Age 69?
For men ages 70 to 74, the American Cancer Society recommends an individual conversation about whether to continue screening. Overall health, previous PSA results, life expectancy, and personal preferences all matter.
Routine screening is generally not recommended beginning at age 75. However, a very healthy person between 75 and 79 may still choose screening after reviewing the possible benefits and harms with a healthcare professional.
Screening is discouraged after age 80 and for people who are not expected to live at least another 10 years. This is because prostate cancer often grows slowly, while follow-up testing and treatment can cause immediate harm.
Other professional organizations may recommend different starting ages or intervals. Therefore, we encourage an informed conversation instead of relying on age alone.
Why Did the Recommendation Change?
The American Cancer Society last issued a major prostate screening guideline in 2010. At that time, concerns about unnecessary biopsies and treatment led many experts to be cautious about routine PSA screening.
Since then, evidence supporting the benefits of PSA-based screening has grown. Healthcare professionals also have better ways to evaluate an elevated PSA before recommending a biopsy.
For example, the new guideline recommends repeating an elevated PSA test, usually within two weeks to three months. If it remains elevated, a prostate MRI or validated biomarker test may help determine whether a biopsy is appropriate.
These additional steps may help identify dangerous cancers while reducing unnecessary procedures for cancers that are unlikely to cause harm.
What Are the Possible Harms of Screening?
Screening can be valuable, but it is not risk-free.
A PSA test can produce a false-positive result, meaning the result appears concerning even though cancer is not present. This can lead to worry and additional testing. A prostate biopsy may cause pain, bleeding, or infection.
Screening can also find slow-growing cancers that would never have caused symptoms during a person’s lifetime. This is called overdiagnosis. Treating such a cancer may expose someone to urinary problems, sexual side effects, or bowel problems without improving their health or extending their life.
For these reasons, we believe every screening decision should include an honest discussion of both benefits and limitations.
Prostate Cancer Matters in Minnesota
Prostate cancer has a significant effect on Minnesota families. According to the Minnesota Department of Health, an average of 4,210 prostate cancers were diagnosed each year from 2017 through 2021. During the same period, an average of 585 Minnesota men died from the disease annually.
The American Cancer Society estimates that prostate cancer will be diagnosed in more than 333,000 men nationwide in 2026. It remains the second-leading cause of cancer death among men in the United States.
These numbers are important. Still, screening should never become a one-size-fits-all decision. Family history, race, age, other health conditions, and personal priorities can change what makes sense for each person.
Screening Is Different From Evaluating Symptoms
Screening means checking someone who does not have symptoms. Anyone experiencing prostate or urinary symptoms should seek medical evaluation rather than waiting for the next recommended screening age.
Symptoms that deserve a conversation with a healthcare professional include:
- Difficulty starting or stopping urination
- A weak or interrupted urine stream
- Frequent urination, especially at night
- Pain or burning during urination
- Blood in the urine or semen
- Persistent pain in the back, hips, or pelvis
These symptoms do not necessarily mean cancer is present. Many common, noncancerous prostate conditions can cause similar problems. Still, we encourage prompt evaluation so the cause can be identified.
Prepare for a Prostate Screening Conversation
Before an appointment, consider gathering the following information:
- Whether a father, brother, or son has had prostate cancer
- The relative’s age when cancer was diagnosed
- Any known inherited cancer-related gene changes in the family
- Previous PSA results
- Current urinary or pelvic symptoms
- Medications and supplements
- Questions about the benefits, costs, and possible follow-up tests
Bringing this information helps us have a more useful and personal conversation with you.
Compassionate, Informed Care in St. Cloud
At Aslan Health, we view preventive care as part of caring for the whole person: physically, emotionally, and spiritually. A cancer screening decision may bring anxiety, especially when cancer has affected someone close to us.
We believe every person deserves dignity, clear information, and compassionate support. Prayer can provide comfort and hope, but it does not replace appropriate medical evaluation, screening, or treatment.
This article provides general education and is not a personal diagnosis or treatment recommendation.
If you are approaching the recommended screening age, have a family history of prostate cancer, or are experiencing prostate-related symptoms, schedule an annual physical with us. We can review your health history, discuss your individual risk, and help you understand the next appropriate step.
Book an appointment online or call us at 320-297-6800. Our clinic is located at 1400 West St. Germain Street in downtown St. Cloud, Minnesota. We provide low-cost, self-pay primary care, annual physicals, prostate care, and on-site lab services.
References
- KFF Health News: Cancer news roundup, November 13, 2026
- American Cancer Society: 2026 prostate cancer screening guideline
- American Cancer Society: Announcement and explanation of the updated guideline
- National Cancer Institute: PSA test facts, benefits, and potential harms
- Minnesota Department of Health: Prostate Cancer in Minnesota
- Aslan Health: Services and mission
- Aslan Health: Contact information